Ranitidine (State of Florida DOH Central Pharmacy)
Welcome to the PulseAid listing for the Ranitidine drug offered from State of Florida DOH Central Pharmacy. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | State of Florida DOH Central Pharmacy |
NON-PROPRIETARY NAME: | Ranitidine |
SUBSTANCE NAME: | RANITIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
Ranitidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Ranitidine from State of Florida DOH Central Pharmacy |
LABELER NAME: | State of Florida DOH Central Pharmacy |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53808-0774_8ec6d8b3-9152-4154-91ea-48ab5bfd1968 |
PRODUCT NDC: | 53808-0774 |
APPLICATION NUMBER: | ANDA075180 |
Other RANITIDINE Pharmaceutical Manufacturers / Labelers: